What is the clinical and cost effectiveness of catheter-based intravascular blood pumps, such as Impella, for heart failure, cardiogenic shock, acute coronary syndrome, or during high-risk percutaneous coronary intervention?
Year: 2026
Type: article
Abstract: No direct evidence for the clinical and cost-effectiveness of Impella for heart failure, cardiogenic shock, or acute coronary syndrome was identified. Available studies highlight potential benefits and significant risks, emphasizing the need for further research.
Author: Tripdatabase
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7223674257